Article Text

Download PDFPDF
Prosthesis-patient mismatch: definition, clinical impact, and prevention
  1. P Pibarot,
  2. J G Dumesnil
  1. Research Group in Valvular Heart Disease, Laval Hospital Research Centre/Quebec Heart Institute, Laval University, Sainte-Foy, Quebec, Canada
  1. Correspondence to:
    Dr Philippe Pibarot
    Laval Hospital Research Centre, 2725 chemin Sainte-Foy, Sainte-Foy, Quebec, Canada G1V 4G5; philippe.pibarot{at}med.ulaval.ca

Abstract

Prosthesis-patient mismatch (PPM) is present when the effective orifice area of the inserted prosthetic valve is too small in relation to body size. Its main haemodynamic consequence is to generate higher than expected gradients through normally functioning prosthetic valves. This review updates the present knowledge about the impact of PPM on clinical outcomes. PPM is common (20–70% of aortic valve replacements) and has been shown to be associated with worse haemodynamic function, less regression of left ventricular hypertrophy, more cardiac events, and lower survival. Moreover, as opposed to most other risk factors, PPM can largely be prevented by using a prospective strategy at the time of operation.

  • AVR, aortic valve replacement
  • BSA, body surface area
  • CFR, coronary flow reserve
  • EOA, effective orifice area
  • IGA, internal geometric area
  • LV, left ventricular
  • PPM, prosthesis-patient mismatch
  • TPG, transvalvar pressure gradient
  • heart valve disease
  • heart valve prosthesis
  • haemodynamic function
  • Doppler echocardiography
  • aortic stenosis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Published Online First 26 October 2005

  • Drs Pibarot and Dumesnil have received financial support from Medtronic, St Jude Medical, and Edwards Life Science to conduct some of the studies presented in this article. They are also consultants and are on the speakers’ bureaus of St Jude Medical and Medtronic.

Linked Articles

  • Editorial
    BMJ Publishing Group Ltd and British Cardiovascular Society